drugset / Trial / NCT01035346

Study Evaluating The Efficacy Of A Novel Ibuprofen Formulation On Fever In Patients With An Uncomplicated Acute Infection

NCT01035346 ↗

Phase 3 Terminated 16 enrolled Pfizer
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This single-dose trial will evaluate the efficacy of a novel ibuprofen formulation compared to placebo in patients with a fever due to an uncomplicated acute infection.

Timeline

Start
2010-01
Primary completion
2011-05
Completion
2011-05

Outcome

Missed primary endpoint

registry analysis (superiority or other test); Placebo vs Ibuprofen Sodium; p = 0.228; Least-squares (LS) mean difference 8.33 (95% CI -7.94 to 24.60); ANOVA; NCT01035346 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Ibuprofen Small molecule 400 mg —

Indications